Brief: Acurx Pharmaceuticals Reports Q2 Loss Per Share Of $0.26
15/08/2022 12:33
Aug 15 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS SECOND QUARTER 2022
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.26
* ENDED Q2 ON JUNE 30, 2022, WITH CASH TOTALING $9.1 MILLION
COMPARED TO $13.1 MILLION AS OF DECEMBER 31, 2021
Source text for Eikon: ID:nPn25P6n5a
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln